Resmed (RSMDF) Cash from Operations Growth (3y) (2012 - 2026)
Powered by 
Analysis
Resmed (RSMDF) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | 27.41% |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 16.81% |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | 27.02% |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 22.38% |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | 30.85% |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 168.71% |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | 16.21% |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | 12.26% |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 9.30% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 24.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.18% |
| Mar 31, 2026 | 25.17% |
| Dec 31, 2025 | 38.23% |
| Sep 30, 2025 | 117.15% |
| Jun 30, 2025 | 89.25% |
| Mar 31, 2025 | 70.17% |
| Dec 31, 2024 | 11.96% |
| Sep 30, 2024 | 90.91% |
| Jun 30, 2024 | 24.78% |
| Mar 31, 2024 | 27.00% |
| Dec 31, 2023 | 17.10% |
| Sep 30, 2023 | 25.74% |
| Jun 30, 2023 | -10.42% |
| Mar 31, 2023 | 5.64% |
| Dec 31, 2022 | 22.53% |
| Sep 30, 2022 | -34.96% |
| Jun 30, 2022 | -17.55% |
| Mar 31, 2022 | -5.61% |
| Dec 31, 2021 | 19.31% |
| Sep 30, 2021 | -49.84% |